Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 217-691-1 | CAS number: 1931-62-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
In a dermal sensitization study conducted according to OECD 429 with OO-tert-butyl monoperoxymaleate (47.3% peroxide content) dissolved in AOO (4:1 (v/v) acetone / olive oil), young adult female CBA/CaOlaHsd mice (5 per dose group) were tested at concentrations of 3.125% (v/v), 6.25 % (v/v) and 12.5 % (v/v) in a local lymph node assay (LLNA). Each of the three tested concentrations exceeded the stimulation index of 3 (9.5 (3.125%), 10.5 (6.25%), 15.0 (12.5%)). Therefore, an EC3 value could not be calculated. In this study, OO-tert-butyl monoperoxymaleate is a dermal sensitizer.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2016-09-29 to 2017-07-26
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Specific details on test material used for the study:
- - Name: OO-tert-butyl monoperoxymaleate
- CAS No.: 1931-62-0
- Batch No.: M-151001
- Physical State: solid
- Colour: white
- Purity: 47.3% peroxide (range 45-50 %); rest phlegmatizer (Triacetin, CAS: 102-76-1)
- Storage Conditions: maximum + 30 °C - Species:
- mouse
- Strain:
- other: CBA/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Envigo (formed partially from Harlan in September 2015), 5800 AN Venray, The Netherlands
- Females (if applicable) nulliparous and non-pregnant: yes
- Microbiological status of animals, when known: The animals were derived from a controlled full-barrier maintained breeding system (SPF).
- Age at study initiation: 8-9 weeks
- Weight at study initiation: between 16.5 and 21.3 g
- Housing: The animals were kept in groups of 5 animals in IVC cages, type II L, polysulphone cages on Altromin saw fibre bedding
- Diet (e.g. ad libitum): ad libitum (Altromin 1324 maintenance diet for rats and mice)
- Water (e.g. ad libitum): ad libitum (tap water, sulphur acidified to a pH value of approx. 2.8)
- Acclimation period: at least five days
ENVIRONMENTAL AND HOUSING CONDITIONS
- Temperature: 22 ± 3 °C
- Relative humidity: 55 ± 10%
- Photoperiod (hrs dark / hrs light): 12/12
- Air change: at least 10 x/hour - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 0, 3.125%, 6.25% and 12.5% (w/v)
- No. of animals per dose:
- - Main experiment: 5 mice/ group
- Details on study design:
- See "Any other information on materials and methods incl. tables" below.
- Positive control substance(s):
- other: phenylendiamine
- Positive control results:
- A shared positive control was performed concomitantly; using 5 animals. The positive-control substance exceeded the stimulation index of 3 confirming the reliability of the test system (see Table 2 in box "Any other information on results").
- Key result
- Parameter:
- SI
- Remarks:
- mean of five animals
- Value:
- 9.5
- Variability:
- SD = 3.0
- Test group / Remarks:
- 3.125%
- Key result
- Parameter:
- SI
- Remarks:
- mean of five animals
- Value:
- 10.5
- Variability:
- SD = 4.1
- Test group / Remarks:
- 6.25%
- Key result
- Parameter:
- SI
- Remarks:
- mean of five animals
- Value:
- 15
- Variability:
- SD = 2.8
- Test group / Remarks:
- 12.5%
- Cellular proliferation data / Observations:
- DETAILS ON STIMULATION INDEX CALCULATION
Please see Table 3 in box "Any other information on results"
EC3 CALCULATION
- The EC3 value (derived by linear interpolation) could not be calculated as the stimulation indices of all concentrations were above 3.
CLINICAL OBSERVATIONS:
- The animals treated with the test item at a concentration of 6.25% and 12.5% showed erythema grade 1 on day 3 which is not considered a sign of excessive irritation. There were no significant clinical observations in any of the animals treated with the test item at a concentration of 3.125 % or the negative control. Neither mortality nor any effects on body weights were observed in any of the animals.
BODY WEIGHTS
- All animals showed the expected weight development, which includes a weight loss of up to 2 g throughout the study. - Interpretation of results:
- Category 1 (skin sensitising) based on GHS criteria
- Conclusions:
- In conclusion, in a mouse local lymph node assay, the test item is considered to be a skin sensitizer.
- Executive summary:
In a dermal sensitization study conducted according to OECD 429 with OO-tert-butyl monoperoxymaleate (47.3 % peroxide content) dissolved in AOO (4:1 (v/v) acetone / olive oil), young adult female CBA/CaOlaHsd mice (5 per dose group) were tested at concentrations of 3.125 % (v/v), 6.25 % (v/v) and 12.5 % (v/v) in a local lymph node assay (LLNA). Due to animal welfare reasons the negative control was shared and a periodically performed positive control (1% Phenlyenediamine in AOO) was used. The animals treated with the test item at concentration of 6.25% and 12.5% showed erythema grade 1 on day 3 which is not considered a sign of excessive irritation. There were no significant clinical observations in any of the animals treated with the test item at a concentration of 3.125% or the negative control. Neither mortality nor any effects on body weights were observed in any of the animals. Each of the three tested concentrations exceeded the stimulation index of 3 (9.5 (3.125%), 10.5 (6.25%), 15.0 (12.5%)). Therefore, an EC3 value could not be calculated. In this study, OO-tert-butyl monoperoxymaleate is a dermal sensitizer.
Reference
Results of the pre-screen tests
Solubility tests
The maximum technically applicable concentration of the test item in the vehicle was found to be 50% in AOO.
Irritation and toxicity test
One of the animals treated with the undiluted test item showed signs of systemic toxicity such as slight reduction in the spontaneous activity, secretion from the eyes on day 4. The local effects at the application sites revealed sticky fur and produced distinctive odour. The animal was found dead on day 6 of the study. The second animal treated with the undiluted test item showed signs of excessive irritation (increased ear thickness > 25%) on day 6 at both application sites. One of the animals treated with the diluted test item at a concentration of 50% showed signs of excessive irritation (increased ear thickness > 25%) on day 6 at the left application site.
One of the animals treated with the diluted test item at a concentration of 25% showed signs of excessive irritation (increased ear thickness > 25%) on day 6 at the left application site. According, to what was observed, the pre-screen test was concluded. All other clinical findings were considered not to be signs of systemic toxicity or signs of excessive irritation.
All surviving animals showed the expected weight development, which includes a weight loss of up to 2 g throughout the duration of the pre-screen test.
Results of the main study
Table 2: Stimulation Indices obtained for the Positive-Control Group
Test Item | Concentration [%] |
Animal Number | Stimulation Index |
Negative Control AOO |
100 | 101 | |
102 | |||
103 | |||
104 | |||
105 | |||
MV | 1.0 | ||
SD | |||
Positive Control Phenylenediamine |
1 | 106 | 7.8 |
107 | 4.7 | ||
108 | 3.5 | ||
109 | 5.7 | ||
110 | 8.7 | ||
MV | 6.1 | ||
SD | 1.9 |
SD = standard deviation; MV = mean value
Table 3: Stimulation Indices obtained in the main experiment
Test Item | Concentration [%] |
Animal Number | Stimulation Index |
Negative Control AOO | 100 | 101 | |
102 | |||
103 | |||
104 | |||
105 | |||
MV | 1.0 | ||
SD | |||
OO-tert-butyl monoperoxy-maleate in AOO | 3.125 | 1 | 5.8 |
2 | 12.5 | ||
3 | 13.5 | ||
4 | 6.8 | ||
5 | 9.1 | ||
MV | 9.5 | ||
SD | 3.0 | ||
OO-tert-butyl monoperoxy-maleate in AOO | 6.25 | 6 | 3.5 |
7 | 10.8 | ||
8 | 12.6 | ||
9 | 15.8 | ||
10 | 9.9 | ||
MV | 10.5 | ||
SD | 4.1 | ||
OO-tert-butyl monoperoxy-maleate in AOO | 12.5 | 11 | 11.9 |
12 | 17.7 | ||
13 | 18.1 | ||
14 | 15.7 | ||
15 | 11.5 | ||
MV | 15.0 | ||
SD | 2.8 |
If not noted individually, the results include both lymph nodes of an animal. SD = standard deviation; MV = mean value
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
In a dermal sensitization study conducted according to OECD 429, female mice were tested positive for OO-tert-butyl monoperoxymaleate. Based on the results, classification of the target substance is warranted (Skin Sens. 1, H317). Subcategorization into 1A/1B is not possible as the EC3 value could not be determined as the stimulation indices of all concentrations were above 3.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.